Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

651 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    New Regulation On Licensing Of Human Medicinal Products

    The New Regulation on Licensing of Human Medicinal Products (the "Regulation") prepared by the TITCK entered into force upon its publication in the Official Gazette numbered 31686 and dated December 11 2021.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    Turkey's Pharmaceuticals And Medical Devices Agency Accepted As Member Of Pharmaceuticals Inspection Co-Operation Scheme

    The Turkish Pharmaceuticals and Medical Devices Agency ("Agency") has become a member of the Pharmaceutical Inspection Co-operation Scheme (PIC/S).
    TurkeyFood, Drugs, Healthcare, Life Sciences
Moroglu Arseven
Moroglu Arseven
  • Article

    TİTCK Extends Validity Period Of GMP Certificates

    The Turkish Medicines and Medical Devices Agency recently announced the extension of the validity period of GMP certificates due to the pandemic.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Esin Attorney Partnership
    Esin Attorney Partnership
  • Article

    TİTCK Publishes Guiding Document For Covid-19 Vaccine Research Groups

    On March 16, 2021, the Turkish Medicine and Medical Devices Authority ("TİTCK") published a document ("Document"), which provides guidance on quality and immunogenicity data that must be submitted...
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Esin Attorney Partnership
    Esin Attorney Partnership
  • Article

    TİTCK Updates The Guidelines On Non-Clinical Assessment For Vaccines

    On 18 May 2021, the Turkish Medicine and Medical Devices Authority (TİTCK) updated the Guidelines on Non-Clinical Assessment for Vaccines ("Guidelines").
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Esin Attorney Partnership
    Esin Attorney Partnership
  • Article

    Year In Healthcare: 2020

    Turkish Medicines and Medical Devices Authority published 280 announcements in 2020. 56 of these announcements are in relation to battle against COVID-19.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Esin Attorney Partnership
    Esin Attorney Partnership
  • Article

    Supply Of Pharmaceutical Products From Abroad And Patent Rights

    The supply of pharmaceutical products to Turkey via the named patient programme (the "NPP") is one of the exceptional importation regimes for pharmaceutical products.
    TurkeyIntellectual Property
    Gün + Partners
    Gün + Partners
  • Article

    Supply Of Pharmaceutical Products From Abroad And Patent Rights

    The supply of pharmaceutical products to Turkey via the named patient programme (the "NPP") is one of the exceptional importation regimes for pharmaceutical products.
    TurkeyIntellectual Property
    Gün + Partners
    Gün + Partners
  • Article

    Biotechnological Inventions

    The Decree Law No: 551 on Protection of Patents, does not specifically refer to the patentability of biotechnological inventions.
    TurkeyIntellectual Property
    Deris Attorney At Law Partnership
    Deris Attorney At Law Partnership
  • Article

    COVID-19: Restrictions On Promoting Medicines

    In accordance with general precautions established by the government due to the COVID-19 pandemic, the Turkish Medicines and Medical Devices Agency published new arrangements in March.
    TurkeyCoronavirus (COVID-19)
    Gün + Partners
    Gün + Partners
  • Article

    Agency Opinion On Health Claims In Food And Food Supplements Can Now Be Requested

    The Regulation on the Use of Health Claims for Food and Food Supplements ("Regulation") entered into force as of its publication on the Official Gazette dated 20 April 2023...
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    Market Availability Of Products And Parallel Trade

    Counterfeit and illicitly traded health products remained a persistent concern in Türkiye throughout 2025, as reflected both in enforcement statistics and in external reporting on supply chain integrity.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    Developments In The Field Of Medical Devices

    After the long-awaited Regulation on Medical Devices numbered 2017/745 ("MDR"), prepared by the EU Commission, has entered into force, Medical Device Regulation...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    European Parliament Approved The Proposal For Postponing The Implementation Date Of Medical Device Regulation No (EU) 2017/745 (MDR)

    The coronavirus (Covid-19) crisis has created extraordinary circumstances that require substantial additional resources and an increased availability of vitally important medical devices.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    Harmonization With The EU Medical Devices Regulation

    Regulations on Medical Devices numbered 2017/745 ("MDR"), prepared by the EU Commission, has been published, and was planned to be enter in force on 26 May 2020.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    COVID-19: Update On Clinical Research Precautions

    An accelerated assessment procedure will be applied to applications regarding COVID-19-related clinical trials.
    TurkeyCoronavirus (COVID-19)
    Gün + Partners
    Gün + Partners
  • Article

    Turkey Limits Product Promotion Representatives' Activities As Part Of Measures Against COVID-19 Pandemic

    On March 19, 2020, the Turkish Medicine and Medical Devices Authority ("TİTCK") announced the suspension of product promotion representatives' visits to pharmacies and health organizations...
    TurkeyCoronavirus (COVID-19)
    Esin Attorney Partnership
    Esin Attorney Partnership
  • Article

    TİTCK Updates FAQ And COVID-19 Measures Documents For Clinical Trials

    On July 25, 2020, the Turkish Medicine and Medical Devices Authority ("TİTCK") updated its Frequently Asked Questions (FAQ) document and COVID-19 measures document regarding clinical trials.
    TurkeyCoronavirus (COVID-19)
    Esin Attorney Partnership
    Esin Attorney Partnership
  • Article

    Market Access- Alternative Reimbursement Models

    For an extended period, the pharmaceutical industry needed a unique model of reimbursement where its conditions could be set together through negotiation with the SSI, and the regular price...
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    Named Patient Program

    Named Patient Programs ("NPP") is one of the exceptional importation regimes of pharmaceuticals without marketing authorization in Turkey or with marketing authorization...
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Showing 41–60 of 651 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics